BCL2L1 and neoplasm: We next determined the mRNA levels of classical markers of apoptosis, two splicing variants of bcl2l1 (Bcl-xL, anti-apoptotic and oncogenic marker [53]; and Bcl-xS, pro-apoptotic tumor suppressor [54]).